Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years
In patients with obstructive HCM, disopyramide is safe and effective at relieving heart failure symptoms from outflow obstruction in a subgroup of patients who were maintained on disopyramide for >5 years.
Authors
- Daniele Massera (ORCID: https://orcid.org/0000-0002-9499-6456)
- Ethan J. Rowin (ORCID: https://orcid.org/0000-0002-3953-0143)
- Maria C. Reuter (ORCID: https://orcid.org/0000-0003-4789-2600)
- Nadia Bokhari (ORCID: https://orcid.org/0000-0001-5237-0220)
- Barry J. Maron (ORCID: https://orcid.org/0000-0002-1710-8670)
- Mark V. Sherrid (ORCID: https://orcid.org/0000-0003-4972-7780)
- Martin S. Maron (ORCID: https://orcid.org/0000-0002-9923-3853)
- Isabel Castro Alvarez
- Elizabeth Adlestein (ORCID: https://orcid.org/0009-0009-7240-6644)
- Woon Y Wu
Institutions
- Lahey Medical Center (US)
- Diabetes & Endocrine Associates (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1161/jaha.124.037639
- Citations
- 11
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 15.27